Howard Weisman, Chairman & CEO of BV4 Portfolio Company EKR Therapeutics, Named Ernst & Young Entrepreneur Of The YearŽ 2009 Award Winner For The New Jersey Pharmaceutical Industry
Bedminster, N.J., June 25, 2009 - EKR Therapeutics, Inc., a specialty acute-care pharmaceutical company, today announced that Howard Weisman, Chairman & CEO, is a recipient of an Ernst & Young Entrepreneur Of The Year® award. Mr. Weisman was honored with the prestigious Entrepreneur Of The Year 2009 New Jersey regional award in the category: Pharmaceuticals.
During a black-tie awards ceremony held June 23rd, Weisman was praised for "... being an inspiring CEO ..." who "... understands the healthcare industry as few others do." Among the many accolades accorded Weisman, he was recognized as a driving force behind "EKR's phenomenal growth." Since initiating operations in June 2006, EKR has grown from a start-up situation into a cash-flow positive profitable specialty pharmaceutical company with over 100 employees focused on serving the needs of the acute-care hospital space.
Weisman expressed sincere gratitude to all EKR employees whose support and entrepreneural spirit were behind EKR's growth success. He said, "As further testament to the untiring commitment to excellence by the EKR team, I note that just a few days ago, on June 12th, my friend and co-founder of EKR, Richard DeSimone, was named CFO of the Year by the New Jersey Technology Council."
Contact for EKR Therapeutics
Stuart Z. Levine, Ph.D.
Director, Corp. Communications / Investor Relations